成人肾脏病患者基因检测结果返回的试点研究
该试点研究开发了基因检测结果返回工作流程,对104名具有可操作遗传发现的肾脏病研究参与者进行回顾性再联系,成功再联系64人(62%)并向41人(39%)返回结果。遗传诊断对每位患者的肾脏病护理均有重要影响,但实施过程中面临20多项关键挑战,包括医生基因组学知识缺口。
要点
- 基因检测结果返回在肾脏病学中资源密集但可改善患者护理。
- 成功再联系62%参与者,向39%返回结果,遗传诊断影响护理。
- 医生基因组学知识缺口是结果返回的反复挑战。
核心结论
- 建立肾脏病学基因结果返回基础设施资源密集,但为改善患者护理提供了潜在机会。
研究设计与样本
- 回顾性再联系已招募入生物样本库研究并接受外显子测序的成人肾脏病患者,识别可操作遗传发现。
- 试点队列包括104名具有可操作遗传发现的肾脏病研究参与者,涵盖34种不同单基因肾病病因和5种ACMG推荐返回的医学可操作次要发现单基因疾病。
主要发现
- 成功再联系64名(62%)参与者,向41名(39%)个体返回结果。
- 每个病例的遗传诊断对患者肾脏病护理具有重要影响。
- 通过实施工作和定性访谈,识别出20多项与返回结果相关的关键挑战,医生基因组学知识缺口是反复主题。
临床怎么用
- 迭代应对挑战后形成优化工作流程,包括标准化咨询记录和定制管理建议。
- 每月举办基因组学核心主题教育会议。
- 为需要肾脏病外转诊的患者提供精选专家临床医生列表。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Actionable genetic findings have implications for care of patients with kidney disease, and genetic testing is an emerging tool in nephrology practice. However, there are scarce data regarding best practices for return of results and clinical application of actionable genetic findings for kidney patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We developed a return of results workflow in collaborations with clinicians for the retrospective recontact of adult nephrology patients who had been recruited into a biobank research study for exome sequencing and were identified to have medically actionable genetic findings. RESULTS: Using this workflow, we attempted to recontact a diverse pilot cohort of 104 nephrology research participants with actionable genetic findings, encompassing 34 different monogenic etiologies of nephropathy and five single-gene disorders recommended by the American College of Medical Genetics and Genomics for return as medically actionable secondary findings. We successfully recontacted 64 (62%) participants and returned results to 41 (39%) individuals. In each case, the genetic diagnosis had meaningful implications for the patients' nephrology care. Through implementation efforts and qualitative interviews with providers, we identified over 20 key challenges associated with returning results to study participants, and found that physician knowledge gaps in genomics was a recurrent theme. We iteratively addressed these challenges to yield an optimized workflow, which included standardized consultation notes with tailored management recommendations, monthly educational conferences on core topics in genomics, and a curated list of expert clinicians for patients requiring extranephrologic referrals. CONCLUSIONS: Developing the infrastructure to support return of genetic results in nephrology was resource-intensive, but presented potential opportunities for improving patient care. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2020_04_16_12481019.mp3.
引用
- Nestor JG, Marasa M, Milo-Rasouly H, et al. Pilot Study of Return of Genetic Results to Patients in Adult Nephrology. Clin J Am Soc Nephrol. 2020. PMID: 32299846. doi:10.2215/CJN.12481019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。